Shanker M.C
Shanker M.C has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Boddula Prathusha Laxmi
Department of Artificial Intelligence and Data Science, R.M.K. College of Engineering and Technology, India
1 shared publication - D. Arul Kumar
Associate Professor, Department of ECE, Panimalar Engineering College, Chennai, Tamil Nadu, India
1 shared publication - G. Sandra Karunya1 shared publication
- Gokula Krishnan Vasudevan
Professor, Department of Computer Science and Engineering, Easwari Engineering College, Chennai, Tamil Nadu, India
1 shared publication - Kaviarasan Solayan
Department of CSE, Panimalar Engineering College, Poonamallee, Chennai-600123, Tamil Nadu, India
1 shared publication
Latest Publications
- 10 April 2026
- Published by VFAST Research Platform in VFAST Transactions on Software Engineering
- Vol. 14 (2) , 129-142
A Modified Generative Adversarial Network-based Drug Discovery Model for Accelerating Biomolecular Interaction Predictions
The drug discovery model for accelerating biomolecular interaction predictions employs sophisticated deep learning methodologies to recognize and foresee drug-target molecule interactions. This model makes use of large-scale databases such as GDSC and CCLE to increase the precision of the interaction mapping. Drug development is accelerated due to the time and cost savings. This paper proposes a modified One-Dimensional Convolutional Wasserstein Generative Adversarial Network (1D-CWGAN) for improving drug response prediction by tackling data imbalance in biomolecular datasets. The framework that is put forward mixes data augmentation using CWGAN with CNN and BiSRU based predictive models, alongside MGS-ROA for effective hyper parameter optimization. Employing sequential feature learning and stabilized adversarial training, the model produces top-notch synthetic samples that boost prediction stability. Tests carried out on GDSC and CCLE datasets show that the proposed CWGAN-BiSRU model is superior in performance, attaining RMSE values of 0.023 and 0.024, respectively, and higher correlation and determination coefficients than traditional machine learning, deep learning, and GAN-based methods. The findings reveal an improved ability to generalize and the efficiency of the proposed method for prediction of biomolecular interactions in drug discovery applications.
- 10 April 2026
- Published by VFAST Research Platform in VFAST Transactions on Software Engineering
- Vol. 14 (2) , 129-142
A Modified Generative Adversarial Network-based Drug Discovery Model for Accelerating Biomolecular Interaction Predictions
The drug discovery model for accelerating biomolecular interaction predictions employs sophisticated deep learning methodologies to recognize and foresee drug-target molecule interactions. This model makes use of large-scale databases such as GDSC and CCLE to increase the precision of the interaction mapping. Drug development is accelerated due to the time and cost savings. This paper proposes a modified One-Dimensional Convolutional Wasserstein Generative Adversarial Network (1D-CWGAN) for improving drug response prediction by tackling data imbalance in biomolecular datasets. The framework that is put forward mixes data augmentation using CWGAN with CNN and BiSRU based predictive models, alongside MGS-ROA for effective hyper parameter optimization. Employing sequential feature learning and stabilized adversarial training, the model produces top-notch synthetic samples that boost prediction stability. Tests carried out on GDSC and CCLE datasets show that the proposed CWGAN-BiSRU model is superior in performance, attaining RMSE values of 0.023 and 0.024, respectively, and higher correlation and determination coefficients than traditional machine learning, deep learning, and GAN-based methods. The findings reveal an improved ability to generalize and the efficiency of the proposed method for prediction of biomolecular interactions in drug discovery applications.